CMS Final Rules for 2018: Preliminary Summary of Rules Affecting Nuclear Medicine/Molecular Imaging

Read a summary of CMS rules on Medicare for 2018 that affect nuclear medicine and molecular imaging. There are some tweaks, but no major surprises or changes. Example: the mandate that referring physician consult AUCs is pushed back from 2018 to 2020.  {read more here}

“The feasibility of 18F-FDG PET/MRI for diagnosing pain generators in chronic sciatica has been demonstrated, revealing various possible etiologies,” Biswal et al. report. {read more here}

Insights derived from FDG PET could improve treatment selection for patients with advanced non-small cell lung cancer. The study is presented in the featured clinical investigation article of the November issue of The Journal of Nuclear Medicine.  {read more here}

“Now that we know where Alzheimer’s disease begins, we can improve the diagnostics by focusing more clearly on these parts of the brain, for example in medical imaging examinations with a PET camera”, says Oskar Hansson, professor at Lund University, and medical consultant at Skåne University Hospital. {read more here}